Literature DB >> 8687105

Biological activities of phthalocyanines. XVII histopathologic evidence for different mechanisms of EMT-6 tumor necrosis induced by photodynamic therapy with disulfonated aluminum phthalocyanine or photofrin.

P Margaron1, P Madarnas, R Quellet, J E Van Lier.   

Abstract

The necrosis of EMT-6 mammary murine tumors induced by photodynamic therapy (PDT) with Photofrin (PII) or disulfonated aluminum phthalocyanine (AlPcS2) was studied. Attention was given to the spontaneous evolution of angiogenesis and necrosis of such tumors in order to determine the most appropriate moment for treatment. On day 6 after tumor cell inoculation, mice were injected with photosensitizer followed by exposure to red light 24 h later, at which time optimal dye concentrations were reached in the tumor. Animals were sacrificed 3 h or 24 h after illumination and tissues were prepared for histology. Prominent cytopathic alterations were already observed at 3 h and there was massive necrosis at 24 h. In the case of PII vascular damage, congestion and hemorrhage were already present at 3 h and these changes account for the subsequent tumor necrosis through hemorrhagic infarction. With AlPcS2 these early vascular alterations were much less evident and only focal at 24 h, suggesting that AlPcS2-PDT mediated tumor necrosis involves to a large extent direct tumor cell damage.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8687105

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  6 in total

1.  Pentalysine beta-carbonylphthalocyanine zinc: an effective tumor-targeting photosensitizer for photodynamic therapy.

Authors:  Zhuo Chen; Shanyong Zhou; Jincan Chen; Yicai Deng; Zhipu Luo; Hongwei Chen; Michael R Hamblin; Mingdong Huang
Journal:  ChemMedChem       Date:  2010-06-07       Impact factor: 3.466

2.  Photodynamic therapy of early squamous cell carcinoma with tetra(m-hydroxyphenyl)chlorin: optimal drug-light interval.

Authors:  S Andrejevic-Blant; C Hadjur; J P Ballini; G Wagnières; C Fontolliet; H van den Bergh; P Monnier
Journal:  Br J Cancer       Date:  1997       Impact factor: 7.640

3.  Serum albumin as a vehicle for zinc phthalocyanine: photodynamic activities in solid tumour models.

Authors:  C Larroque; A Pelegrin; J E Van Lier
Journal:  Br J Cancer       Date:  1996-12       Impact factor: 7.640

4.  Apoptosis induced in vivo by photodynamic therapy in normal brain and intracranial tumour tissue.

Authors:  L Lilge; M Portnoy; B C Wilson
Journal:  Br J Cancer       Date:  2000-10       Impact factor: 7.640

5.  Water-soluble aluminium phthalocyanine-polymer conjugates for PDT: photodynamic activities and pharmacokinetics in tumour-bearing mice.

Authors:  N Brasseur; R Ouellet; C La Madeleine; J E van Lier
Journal:  Br J Cancer       Date:  1999-07       Impact factor: 7.640

6.  Photodynamic therapy for experimental tumors using ATX-S10(Na), a hydrophilic chlorin photosensitizer, and diode laser.

Authors:  M Mori; I Sakata; T Hirano; A Obana; S Nakajima; M Hikida; T Kumagai
Journal:  Jpn J Cancer Res       Date:  2000-07
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.